Literature DB >> 23611349

Neuropsychiatry of corticobasal degeneration and progressive supranuclear palsy.

Marla B Bruns1, Keith A Josephs.   

Abstract

Corticobasal syndrome (CBS) and progressive supranuclear palsy syndrome (PSPS) are two of the atypical Parkinsonism syndromes, in that patients exhibit rigidity, occasional tremor and postural instability, but do not symptomatically respond to dopamine replacement. CBS and PSPS can often present with complex cognitive difficulties and neuropsychiatric disturbances. Symptoms of depression, apathy, or agitation can be subtle and are often overlooked as reactions to learning a new diagnosis of Parkinsonism. These symptoms may be the earliest presenting evidence of CBS or PSPS, and these syndromes can be misdiagnosed with a primary psychiatric disorder rather than a neurodegenerative condition. Patients may be inappropriately treated with antipsychotic medications that exacerbate the extra-pyramidal motor features of the syndromes. When symptoms are considered to comprise a neurodegenerative syndrome, it may be an inaccurate diagnosis as many features of CBS and PSPS not only overlap with each other, but also with other dementia syndromes. This review discusses similarities and differences between the syndromes of CBS and PSPS in terms of neuropsychiatric features. Improved characterization of the clinical syndromes is necessary to better predict underlying pathology. Improved education about these diseases would help patients, caregivers and clinicians to anticipate symptom progression and avoid premature nursing home placement.

Entities:  

Mesh:

Year:  2013        PMID: 23611349     DOI: 10.3109/09540261.2013.766154

Source DB:  PubMed          Journal:  Int Rev Psychiatry        ISSN: 0954-0261


  8 in total

Review 1.  Psychiatric issues in cognitive impairment.

Authors:  Dag Aarsland; John-Paul Taylor; Daniel Weintraub
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

Review 2.  Challenges of multimorbidity of the aging brain: a critical update.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2014-08-05       Impact factor: 3.575

Review 3.  Depressive symptoms in neurodegenerative diseases.

Authors:  Miquel Baquero; Nuria Martín
Journal:  World J Clin Cases       Date:  2015-08-16       Impact factor: 1.337

Review 4.  Frontotemporal lobar degeneration: current perspectives.

Authors:  Lina Riedl; Ian R Mackenzie; Hans Förstl; Alexander Kurz; Janine Diehl-Schmid
Journal:  Neuropsychiatr Dis Treat       Date:  2014-02-13       Impact factor: 2.570

5.  Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition.

Authors:  Jeffrey Cummings; Jacobo Mintzer; Henry Brodaty; Mary Sano; Sube Banerjee; D P Devanand; Serge Gauthier; Robert Howard; Krista Lanctôt; Constantine G Lyketsos; Elaine Peskind; Anton P Porsteinsson; Edgardo Reich; Cristina Sampaio; David Steffens; Marc Wortmann; Kate Zhong
Journal:  Int Psychogeriatr       Date:  2014-10-14       Impact factor: 3.878

6.  Advancing functional dysconnectivity and atrophy in progressive supranuclear palsy.

Authors:  Jesse A Brown; Alice Y Hua; Andrew Trujllo; Suneth Attygalle; Richard J Binney; Salvatore Spina; Suzee E Lee; Joel H Kramer; Bruce L Miller; Howard J Rosen; Adam L Boxer; William W Seeley
Journal:  Neuroimage Clin       Date:  2017-09-12       Impact factor: 4.881

7.  Tauopathy induced by low level expression of a human brain-derived tau fragment in mice is rescued by phenylbutyrate.

Authors:  Marie K Bondulich; Tong Guo; Christopher Meehan; John Manion; Teresa Rodriguez Martin; Jacqueline C Mitchell; Tibor Hortobagyi; Natalia Yankova; Virginie Stygelbout; Jean-Pierre Brion; Wendy Noble; Diane P Hanger
Journal:  Brain       Date:  2016-06-12       Impact factor: 13.501

8.  Depressive Symptom Profiles Predict Specific Neurodegenerative Disease Syndromes in Early Stages.

Authors:  Suzanne M Shdo; Kamalini G Ranasinghe; Virginia E Sturm; Katherine L Possin; Brianne M Bettcher; Melanie L Stephens; Jessica M Foley; Shou-Chin Christine You; Howard J Rosen; Bruce L Miller; Joel H Kramer; Katherine P Rankin
Journal:  Front Neurol       Date:  2020-05-29       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.